These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9455944)

  • 1. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
    Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteatoma: a molecular and cellular puzzle.
    Albino AP; Kimmelman CP; Parisier SC
    Am J Otol; 1998 Jan; 19(1):7-19. PubMed ID: 9455941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
    Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA analysis of human cholesteatomas.
    Desloge RB; Carew JF; Finstad CL; Steiner MG; Sassoon J; Levenson MJ; Staiano-Coico L; Parisier SC; Albino AP
    Am J Otol; 1997 Mar; 18(2):155-9. PubMed ID: 9093669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of the proliferative capacity of cholesteatomas].
    Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
    Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
    Ghanooni R; Decaestecker C; Simon P; Gabius HJ; Hassid S; Choufani G
    Hear Res; 2006 Apr; 214(1-2):7-16. PubMed ID: 16513304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas.
    Choufani G; Mahillon V; Decaestecker C; Lequeux T; Danguy A; Salmon I; Gabius HJ; Hassid S; Kiss R
    Laryngoscope; 1999 Nov; 109(11):1825-31. PubMed ID: 10569415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell profile in invasive cholesteatomas: preliminary findings.
    Hussein MR; Sayed RH; Abu-Dief EE
    Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
    Choufani G; Ghanooni R; Decaestecker C; Delbrouck K; Simon P; Schüring MP; Zick Y; Hassid S; Gabius HJ; Kiss R
    Laryngoscope; 2001 Sep; 111(9):1656-62. PubMed ID: 11568623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
    Sudhoff H; Tos M
    Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
    Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
    Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
    Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.